Latest Sustainability News

Spenda Limited has accelerated its strategic turnaround by slashing operating costs by about $400,000 per month and locking in new retail contracts, while eyeing divestments and emerging tech opportunities.

RemSense Technologies has raised $1.21 million through a heavily subscribed placement, targeting upgrades to its virtualplant platform and AI image analysis capabilities.

Kingston Resources has boosted the Southern Ore Zone (SOZ) Mineral Resource at Mineral Hill by 50%, expanding the mining inventory and underpinning plans for reserve growth and plant expansion.

European Metals Holdings reveals lithium chemical plant design improvements at Cinovec that could slash reagent and power costs by over US$54 million annually, potentially boosting the project’s pre-tax NPV beyond US$1.455 billion.

Echelon Resources has secured a three-year extension to its gas supply agreement with Genesis Energy, underpinning continued sales of Kupe gas at market-linked prices and supporting New Zealand’s domestic energy needs.

Tasmea Limited is set to acquire JPS Group for up to A$75 million, securing a foothold in Australia’s growing LNG and energy infrastructure sectors with a Tier-1 client base and a unique tech-enabled isolation technology.

Aguia Resources reports significant cost reductions and stable high-grade gold feed at its Santa Barbara Gold Project, despite a temporary dip in production as underground development advances.

Asset Vision has boosted its FY26 annual recurring revenue run rate to $6.4 million, driven by multiple new contracts across transport, social housing, and civic infrastructure sectors.

Matrix Composites & Engineering has landed a significant A$34 million subsea buoyancy contract, boosting its FY27 workload as it navigates a major acquisition proposal.

Sprintex has landed a three-year exclusive distribution agreement in Taiwan with Shing Yu, including a paid trial at TSMC’s wastewater facilities aiming to cut energy use by half.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.